Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Nov 23;13:1054968. doi: 10.3389/fimmu.2022.1054968

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Nikolic, Suwandi, Wesselius, Laban, Joosten, Sonneveld, Mul, Aanstoot, Kaddis, Zwaginga and Roep

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

TolDC treatment does not change PBMC subsets. (A) Frequency of leukocyte subsets determined in full blood by flow cytometry. Timepoint before leukapheresis is indicated with black dashed arrow (Ph) and tolDC treatment with black arrows. (B) Lymphocytes (black squares) and monocytes (grey squares) determined in absolute cell counts. Symbols represent the mean value ± SD of all patients. TolDC treatments are indicated with black arrows, dashed arrow (Ph) indicates timepoint before leukapheresis.